140 related articles for article (PubMed ID: 26785948)
21. Roles and Regulation of BCL-xL in Hematological Malignancies.
Morales-Martínez M; Vega MI
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216310
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy.
Kawiak A; Kostecka A
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053443
[TBL] [Abstract][Full Text] [Related]
23. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
[TBL] [Abstract][Full Text] [Related]
24. RHAMM
Chen X; Lee SK; Song M; Zhang T; Han MS; Chen YT; Chen Z; Ma X; Tung CH; Du YN
Mol Ther Oncolytics; 2021 Dec; 23():277-287. PubMed ID: 34761107
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.
Young A; Bu W; Jiang W; Ku A; Kapali J; Dhamne S; Qin L; Hilsenbeck SG; Du YN; Li Y
Cancer Prev Res (Phila); 2022 Jan; 15(1):3-10. PubMed ID: 34667127
[TBL] [Abstract][Full Text] [Related]
26. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X
Thummuri D; Khan S; Underwood PW; Zhang P; Wiegand J; Zhang X; Budamagunta V; Sobh A; Tagmount A; Loguinov A; Riner AN; Akki AS; Williamson E; Hromas R; Vulpe CD; Zheng G; Trevino JG; Zhou D
Mol Cancer Ther; 2022 Jan; 21(1):184-192. PubMed ID: 34667112
[TBL] [Abstract][Full Text] [Related]
27. Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling.
Gu L; Surolia R; Larson-Casey JL; He C; Davis D; Kang J; Antony VB; Carter AB
Cell Death Differ; 2022 Jan; 29(1):118-132. PubMed ID: 34413485
[TBL] [Abstract][Full Text] [Related]
28. Functional impact of cancer patient-associated Bcl-xL mutations.
Zhang T; Na JH; Li S; Chen Z; Zhang G; Pang S; Daniyan AF; Li Y; Shi L; Du YN
MedComm (2020); 2020 Dec; 1(3):328-337. PubMed ID: 34308416
[TBL] [Abstract][Full Text] [Related]
29. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.
Dou Z; Zhao D; Chen X; Xu C; Jin X; Zhang X; Wang Y; Xie X; Li Q; Di C; Zhang H
J Exp Clin Cancer Res; 2021 Jun; 40(1):194. PubMed ID: 34118966
[TBL] [Abstract][Full Text] [Related]
30. Bcl-xL: A Focus on Melanoma Pathobiology.
Lucianò AM; Pérez-Oliva AB; Mulero V; Del Bufalo D
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803452
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant,
Makhafola TJ; Mbele M; Yacqub-Usman K; Hendren A; Haigh DB; Blackley Z; Meyer M; Mongan NP; Bates DO; Dlamini Z
Front Oncol; 2020; 10():547392. PubMed ID: 33163396
[TBL] [Abstract][Full Text] [Related]
32. Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres.
Fanfone D; Idbaih A; Mammi J; Gabut M; Ichim G
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023187
[TBL] [Abstract][Full Text] [Related]
33. Chronic electronic cigarette use elicits molecular changes related to pulmonary pathogenesis.
Marshall K; Liu Z; Olfert IM; Gao W
Toxicol Appl Pharmacol; 2020 Nov; 406():115224. PubMed ID: 32890605
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer.
D'Aguanno S; Del Bufalo D
Cells; 2020 May; 9(5):. PubMed ID: 32455818
[TBL] [Abstract][Full Text] [Related]
35. Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program.
Kanchan K; Iyer K; Yanek LR; Carcamo-Orive I; Taub MA; Malley C; Baldwin K; Becker LC; Broeckel U; Cheng L; Cowan C; D'Antonio M; Frazer KA; Quertermous T; Mostoslavsky G; Murphy G; Rabinovitch M; Rader DJ; Steinberg MH; Topol E; Yang W; Knowles JW; Jaquish CE; Ruczinski I; Mathias RA
Stem Cell Res; 2020 Jul; 46():101803. PubMed ID: 32442913
[TBL] [Abstract][Full Text] [Related]
36. The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.
Bessou M; Lopez J; Gadet R; Deygas M; Popgeorgiev N; Poncet D; Nougarède A; Billard P; Mikaelian I; Gonzalo P; Rimokh R; Gillet G
Oncogene; 2020 Apr; 39(15):3056-3074. PubMed ID: 32066881
[TBL] [Abstract][Full Text] [Related]
37. miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor.
Zhang T; Choi S; Zhang T; Chen Z; Chi Y; Huang S; Xiang JZ; Du YN
Am J Pathol; 2020 Mar; 190(3):689-701. PubMed ID: 31953039
[TBL] [Abstract][Full Text] [Related]
38. MiR-326: Promising Biomarker for Cancer.
Pan YJ; Wan J; Wang CB
Cancer Manag Res; 2019; 11():10411-10418. PubMed ID: 31849530
[TBL] [Abstract][Full Text] [Related]
39. Grass carp (Ctenopharyngodon idella) Bcl-xl: transcriptional regulation and anti-apoptosis analysis.
Qi G; Yu N; Xu K; Xie X; Mao Y; Chen X; Ran X; Chen X; Lin G; Hu C
Fish Physiol Biochem; 2020 Apr; 46(2):483-500. PubMed ID: 31836954
[TBL] [Abstract][Full Text] [Related]
40. Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck.
Carter RJ; Milani M; Butterworth M; Alotibi A; Harper N; Yedida G; Greaves G; Al-Zebeeby A; Jorgensen AL; Schache AG; Risk JM; Shaw RJ; Jones TM; Sacco JJ; Hurlstone A; Cohen GM; Varadarajan S
Cell Death Dis; 2019 Dec; 10(12):912. PubMed ID: 31801952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
